These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22442883)

  • 1. Trial evaluating DNA/Ad35 prime-boost regimen commences in Africa.
    McEnery R
    IAVI Rep; 2012; 16(1):17. PubMed ID: 22442883
    [No Abstract]   [Full Text] [Related]  

  • 2. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
    Xin KQ; Jounai N; Someya K; Honma K; Mizuguchi H; Naganawa S; Kitamura K; Hayakawa T; Saha S; Takeshita F; Okuda K; Honda M; Klinman DM; Okuda K
    Gene Ther; 2005 Dec; 12(24):1769-77. PubMed ID: 16079886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New oral DNA vaccine funded for trials.
    James JS
    AIDS Treat News; 2000 Jun; (344):3. PubMed ID: 12170972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADVAX, new DNA vaccine in human trial; HIV-negative volunteers needed in New York City or Rochester, NY areas.
    James JS
    AIDS Treat News; 2004 Jun; (402):8. PubMed ID: 15272461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.
    Gudmundsdotter L; Wahren B; Haller BK; Boberg A; Edbäck U; Bernasconi D; Buttò S; Gaines H; Imami N; Gotch F; Lori F; Lisziewicz J; Sandström E; Hejdeman B
    Vaccine; 2011 Jul; 29(33):5558-66. PubMed ID: 21300092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime-boost immunization strategies against HIV.
    Barnett SW; Klinger JM; Doe B; Walker CM; Hansen L; Duliège AM; Sinangil FM
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S299-309. PubMed ID: 9814958
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
    Thapinta D; Jenkins RA
    Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II prime-boost trial begins in the U.S.
    McEnery R
    IAVI Rep; 2009; 13(4):18. PubMed ID: 20225577
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of DNA vaccine and adenovirus vector by cutaneous administration induced strong HIV-specific cellular immune responses in mice.
    Takakura M; Okuda K; Matsuda T; Takeshita F; Takakura H; Ikezawa Z; Xin KQ
    Vaccine; 2005 Jan; 23(7):847-8. PubMed ID: 15603883
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.
    Eller MA; Eller LA; Opollo MS; Ouma BJ; Oballah PO; Galley L; Karnasuta C; Kim SR; Robb ML; Michael NL; Kibuuka H; Wabwire-Mangen F; Graham BS; Birx DL; de Souza MS; Cox JH
    Vaccine; 2007 Nov; 25(45):7737-42. PubMed ID: 17920731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost strategies in DNA vaccines.
    Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First AIDS vaccine trial begins in Africa.
    AIDS Patient Care STDS; 1999 May; 13(5):309-10. PubMed ID: 10356817
    [No Abstract]   [Full Text] [Related]  

  • 15. Two new AIDS vaccine trials initiated in Africa.
    Kresge KJ
    IAVI Rep; 2006; 10(6):15. PubMed ID: 20213985
    [No Abstract]   [Full Text] [Related]  

  • 16. NIAID declines to proceed with HIV vaccine trial.
    AIDS Policy Law; 2008 Aug; 23(9):1, 4. PubMed ID: 18780467
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV vaccine in healthy volunteers gets testing approval.
    AIDS Patient Care STDS; 2010 Mar; 24(3):198. PubMed ID: 20238443
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.
    Kelleher AD; Puls RL; Bebbington M; Boyle D; Ffrench R; Kent SJ; Kippax S; Purcell DF; Thomson S; Wand H; Cooper DA; Emery S
    AIDS; 2006 Jan; 20(2):294-7. PubMed ID: 16511428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failed HIV vaccine may have increased vulnerability to infection.
    Clin Infect Dis; 2008 Jan; 46(1):iii. PubMed ID: 18181273
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of multicomponent DNA vaccination strategies against HIV.
    Kim JJ; Weiner DB
    Curr Opin Mol Ther; 1999 Feb; 1(1):43-9. PubMed ID: 11249683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.